GlassScriptPhysician profile
Ryan C Meineke
NPI 1851579015
$4,252.20
in general payments reported to CMS, 2019-2025
19 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $68.13 · 2021: $106 · 2022: $212 · 2023: $382 · 2024: $2,460 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765 · Travel and Lodging: $1,416 · Long Term Medical Supply Or Device Loan: $66.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,764.75 |
| Travel and Lodging | $1,415.76 |
| Long Term Medical Supply Or Device Loan | $66.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,699.94 | 2021-2025 | Infinity, Prophecy, Flexband |
| Bioventus LLC | $407.53 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Biotissue Holdings INC. | $307.39 | 2023 | |
| Wright Medical Technology, INC. | $158.77 | 2019 | |
| Medical Device Business Services, INC. | $114.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $114.15 | 2019 | |
| Zimmer Biomet Holdings, INC. | $106.75 | 2019-2021 | |
| Integra Lifesciences Corporation | $66.46 | 2025 | Micromatrix |
| Depuy Synthes Sales INC. | $48.03 | 2020-2023 | Orthovisc |
| Acumed LLC | $46.51 | 2023-2025 | Acumed, Acumed |
| Elevate Surgical Co | $33.82 | 2024-2025 | |
| Paragon 28, INC. | $31.61 | 2022 | |
| Smith+Nephew, INC. | $30.91 | 2024 | Katalyst Bipolar Radial Head System |
| Bausch & Lomb Americas INC. | $24.53 | 2023 | Stellaris |
| Vertex Pharmaceuticals Incorporated | $19.13 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $17.82 | 2019 | |
| Innovation Technologies INC | $13.05 | 2023 | Irrisept |
| Heron Therapeutics, INC. | $10.93 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Meineke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.